Physician profile
Omar Moore
NPI 1487072245
$687.13
in general payments reported to CMS, 2019-2025
19 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.90 · 2020: $241 · 2021: $123 · 2022: $25.06 · 2023: $22.75 · 2024: $153 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $110.56 | 2022-2025 | |
| Genzyme Corporation | $105.70 | 2020 | |
| Sk Life Science, INC. | $57.61 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $51.72 | 2020-2024 | Austedo Xr |
| Lundbeck LLC | $48.74 | 2023-2024 | Rexulti, Vyepti |
| Ucb, INC. | $47.16 | 2021-2025 | Nayzilam |
| Neurelis, INC. | $32.73 | 2020-2025 | Valtoco |
| Amgen INC. | $32.73 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $31.66 | 2025 | |
| Alnylam Pharmaceuticals INC. | $21.90 | 2020 | |
| Averitas Pharma INC. | $19.00 | 2024 | Qutenza |
| Alexion Pharmaceuticals, INC. | $18.79 | 2020 | |
| Greenwich Biosciences, INC. | $18.49 | 2020 | |
| Axsome Therapeutics, INC. | $17.53 | 2025 | Auvelity |
| Almatica Pharma LLC | $15.98 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $15.90 | 2019 | |
| Zyla Life Sciences, INC. | $14.73 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $13.25 | 2024 | Rexulti |
| Biogen, INC. | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.